The Almighty Buck

Trump's 2021 Budget Drowns Science Agencies in Red Ink, Again (sciencemag.org) 413

It's another sea of red ink for federal research funding programs in President Donald Trump's latest budget proposal. The 2021 budget request to Congress released today calls for deep, often double-digit cuts to R&D spending at major science agencies. From a report: At the same time, the president wants to put more money into a handful of areas -- notably artificial intelligence (AI) and quantum information science (QIS) -- to create the new technology needed for what the budget request calls "industries of the future." Here is a rundown of some of the numbers from the budget request's R&D chapter. (The numbers reflect the portion of each agency's budget classified as research, which in most cases is less than its overall budget.)

1. National Institutes of Health: a cut of 7%, or $2.942 billion, to $36.965 billion.
2. National Science Foundation (NSF): a cut of 6%, or $424 million, to $6.328 billion.
3. Department of Energy's (DOE's) Office of Science: a cut of 17%, or $1.164 billion, to $5.760 billion.
4. NASA science: a cut of 11%, or $758 million, to $6.261 billion.
5. DOE's Advanced Research Projects Agency-Energy: a cut of 173%, which would not only eliminate the $425 million agency, but also force it to return $311 million to the U.S. Department of the Treasury.
6. U.S. Department of Agriculture's (USDA's) Agricultural Research Service: a cut of 12%, or $190 million, to $1.435 billion.
7. National Institute of Standards and Technology: a cut of 19%, or $154 million, to $653 million.
8. National Oceanic and Atmospheric Administration: a cut of 31%, or $300 million, to $678 million.
9. Environmental Protection Agency science and technology: a cut of 37%, or $174 million, to $318 million.
10. Department of Homeland Security science and technology: a cut of 15%, or $65 million, to $357 million.
11. U.S. Geological Survey: a cut of 30%, or $200 million, to $460 million.

ISS

NASA Moves Forward With International Space Station 'Hotel' (fool.com) 90

Last June NASA announced plans to host visitors on the International Space Station for just $35,000 a day.

"And now we know where they'll be sleeping," reports the Motley Fool: Earlier this week, NASA announced that it has selected Axiom Space to build "at least one habitable commercial module to be attached to the International Space Station...." In this particular demonstration project, Axiom will deliver to the ISS an "element" which "will attach to the space station's Node 2 forward port," giving access to the rest of the space station, and also a place for weary private astronauts to lay their heads at night...

"Developing commercial destinations in low-Earth orbit" is a priority for NASA, explains the agency -- whether those destinations are attached to the ISS or not... The "habitable commercial module" that Axiom is building will facilitate onboarding private businesses to do work on the ISS, creating potential new revenue streams to subsidize NASA's more adventurous endeavors farther out from Low Earth Orbit. With NASA's budget today stuck below where it was in 1972 -- the year of America's last crewed mission to the moon -- the agency's going to need significant new funding to perform planned missions to Mars and beyond in future years. If Congress won't pony up additional cash, therefore, the agency may hope to raise cash from private industry...

NASA says it "also plans to issue a final opportunity to partner with the agency in the development of a free-flying, independent commercial destination" at some point in the future. This latter opportunity should be of particular interest to both Axiom and Bigelow -- which, like Axiom, has expressed interest in building its own space stations independent of the ISS.

"If Axiom succeeds in building and operating a commercial space station," writes Axios, "it will mark a turning point for how space is used and who has access to it..."

They also report that Axiom expects to procure flights to the ISS from both SpaceX and Boeing. And when the International Space Station reaches its end-of-life, "Axiom plans to remove its modules and become a free-standing station that can be accessed by the company's customers."
Space

Something In Deep Space Is Sending Signals To Earth In Steady 16-Day Cycles (vice.com) 136

"Scientists have discovered the first fast radio burst that beats at a steady rhythm, and the mysterious repeating signal is coming from the outskirts of another galaxy," reports Vice: A mysterious radio source located in a galaxy 500 million light years from Earth is pulsing on a 16-day cycle, like clockwork, according to a new study. This marks the first time that scientists have ever detected periodicity in these signals, which are known as fast radio bursts (FRBs), and is a major step toward unmasking their sources.

FRBs are one of the most tantalizing puzzles that the universe has thrown at scientists in recent years. First spotted in 2007, these powerful radio bursts are produced by energetic sources, though nobody is sure what those might be... Pulses from these repeat bursts have, so far, seemed somewhat random and discordant in their timing. But that changed last year, when the Canadian Hydrogen Intensity Mapping Experiment Fast Radio Burst Project (CHIME/FRB), a group dedicated to observing and studying FRBs, discovered that a repeater called FRB 180916.J0158+65 had a regular cadence...

While we still don't know what is blasting out these bizarre signals, the discovery of a clear tempo from one of these sources provides a significant lead for scientists to follow.

The Media

Fake News Hoax in Russia Tries Blaming the US For Coronavirus (ibtimes.com) 86

"Russia's intelligence services are apparently behind a well-coordinated social media campaign to blame the U.S. for creating and unleashing the Wuhan coronavirus on the world," reports the International Business Times.

That conclusion comes from the Atlantic Council think tank (founded in 1961), which established its Digital Forensic Research Lab in 2016. Eto Buziashvili, an analyst at the Atlantic Council's Digital Forensic Research Lab, published a report detailing how Russia's state propaganda units are disseminating different versions of conspiracies alleging the coronavirus is a U.S. creation. Western intelligence sources quoted by media said posts blaming the U.S. for attacking China with 2019-nCoV first began appearing on pro-Russia social media outlets such as VK (VKontakte) and Topcor.ru. The fake news has now spread to traditional Russian news media organizations such as Pravda and Izvestia and state propaganda platforms. State-controlled outlets are accusing the U.S. of using bioweapons against China...

A Russian website called Katushya.org says the People's Liberation Army (PLA), China's armed forces, is claiming the coronavirus was artificially produced in U.S. laboratories with the goal of destroying China from within.

"So far, their efforts have gained very little traction," Eto Buziashvili wrote on January 30, while adding that it still "serves as a reminder of Russia's long history of employing anti-U.S. influence operations during public health crises."

But the progressive political magazine Mother Jones argues that pro-Kremlin websites "are just one example of the kinds of outlets trying to capitalize on coronavirus fears. Some YouTube creators have been doing their best to get views and hawk money-making products and services on the backs of coronavirus fears; high-profile right-wing conspiracy theorists like Alex Jones are doing the same. Facebook, Twitter, and YouTube have tried to step up their efforts to curb misinformation linked to the virus, but hoaxes and conspiracies continue to seep through."
NASA

NASA Brings Voyager 2 Fully Back Online, 11.5 Billion Miles From Earth (inverse.com) 56

A reader quotes Inverse: In an incredible feat of remote engineering, NASA has fixed one of the most intrepid explorers in human history. Voyager 2, currently some 11.5 billion miles from Earth, is back online and resuming its mission to collect scientific data on the solar system and the interstellar space beyond.

On Wednesday, February 5 at 10:00 p.m. Eastern, NASA's Voyager Twitter account gave out the good news: Voyager 2 is not only stable, but is back at its critical science mission.

"My twin is back to taking science data, and the team at @NASAJPL is evaluating the health of the instruments after their brief shutoff," the account tweeted... In a statement, NASA confirmed that Voyager 2 is back in business. "Mission operators report that Voyager 2 continues to be stable and that communications between the Earth and the spacecraft are good...."

The fix is no mean feat: It takes 17 hours one-way to communicate with Voyager 2 from Earth, which is the furthest away manmade object in space. That means a single information relay takes 34 hours.

Google

Google Experimented on Its Own Employees To Get Them To Eat Healthier (medium.com) 156

This week Medium's tech blog OneZero published a 4,500-word look at Google's "methodical, iterative" and massive "living experiment" on its own employees to see if they can nudge them into making healthier choices when they eat: The campaign isn't changing just the food itself, but how it's presented. Google's tactics include limiting portion sizes for meat and desserts and redesigning its premises to lead its "users" to choose water and fruit over soda and M&M's. The goal, says Michiel Bakker, Google's director of global workplace programs, is to make the healthy choice the easy choice...

[T]he small changes make big differences. The plates on the buffet line are only eight to 10 inches wide, versus a standard 12 inches, which effectively limits serving sizes. Vegetables always come first on the line, so by the time you get to the meat or the snickerdoodles and chocolate tarts, there's not much space on your plate. "Spa water," bobbing with strawberries or cucumbers or lemons, is everywhere -- and deliberately more accessible than sugary drinks or even bottled water. A burrito at Google weighed in at about 10 ounces -- 60% smaller than the whopping one-pound nine-ounce log filled with similar ingredients that I picked up at a Chipotle near my home in Washington, D.C....

"Early choice architecture focused specifically on the process," said Ravi Dhar, a professor at Yale and the director of the school's Center for Customer Insights, which partners with Google on food research. "You didn't change the set of alternatives, but you rearranged them." So, if the goal was to get people to eat more vegetables, you would make the salad bar the first thing people see in a cafeteria -- hungry people usually grab the first food they see -- and leave it at that. But it turns out that's not enough. You also have to make the vegetables more abundant and more compelling -- and do the opposite for meat.

For example, moving the snacks table 10 feet further from the coffee machine reduced the likelihood of snacking by as much as 23% for men and 17% for women. But "Since then, Google has remade its 1,450 microkitchens. The unhealthy snacks -- now limited for the most part to M&M's and gummy bears -- are well away from the coffee machine, hidden in opaque canisters or in a drawer.

"At the same time, a big bowl of fresh fruit sits alluringly in the center of the counter nearest the coffee machine..."
China

Will China Seize an American Company's Drug For Fighting Coronavirus? (yahoo.com) 142

"Chinese researchers reportedly have applied for a local patent on an experimental Gilead drug that they believe could help fight the novel coronavirus outbreak -- and also significantly bolster Gilead's bottom-line going forward..." reports The Street. "If granted, Gilead will need to get Chinese patent owners on board when it wants to sell the drug for treating the novel coronavirus infection outside China."

"The move is a sign that China views Gilead's therapy as one of the most promising candidates to fight the outbreak that has now claimed almost 500 lives..." Time reports. "While Gilead's experimental drug isn't licensed or approved anywhere in the world, it is being rushed into human trials in China on coronavirus patients after showing early signs of being highly effective."

But China's move concerns Bloomberg Opinion biotech/pharma columnist Max Nisen: If the patent is granted, it will confirm long-standing drugmaker fears about China's commitment to IP protection, raising concern about the industry's future in a crucial market. It also could further erode the already weak incentives for pharma to invest in drugs to combat emerging infectious diseases... [T]he company could see any potential return on the medication curtailed if China starts manufacturing it.

China's increasingly affluent population represents a huge opportunity for drugmakers. Many are investing heavily in the region despite previous data integrity and sales scandals. Leadership has recently demonstrated a greater commitment to IP rights in its initial trade deal with the U.S., but granting this patent could erode trust in the government and scare off foreign drugmakers.

The consequences wouldn't be limited to declining corporate confidence in China, even if this is a one-time emergency event. The world dramatically under-invests in drugs to combat infectious diseases, and a move like this by the Chinese government wouldn't help. Developing such medicines isn't very profitable, compared to drugs for rare diseases and cancer. That's especially true when it comes to emerging viruses, in spite of the obvious risk. Outbreaks are more common in developing countries, which limits pricing power. By the time a company has managed to get approval for any given drug, often a years-long process, there's a good chance that the outbreak will be over.

Seizing the rights to treatments dents drugmakers' already limited incentive to invest in infectious-disease drugs, let alone spend heavily to develop and maintain the ability to respond rapidly to outbreaks and scale up manufacturing. Without the promise of some kind of return, investment is going to dry up. I'm not a rah-rah pharma guy. The industry often abuses the patent system, especially in the U.S., in order to profit for years off of old drugs to the detriment of patients and the health-care system. Its pricing practices are frequently unconscionable. This isn't one of those situations. It's arguably one of the rare cases where the ability of drugmakers to profit needs to be boosted rather than crimped.

Science

A Long-Lost Legendary Roman Fruit Tree Has Been Grown From 2,000-Year-Old Seeds (sciencealert.com) 38

"Scientists have cultivated plants from date palm seeds that languished in ancient ruins and caves for 2,000 years," writes ScienceAlert. schwit1 shared their report: This remarkable feat confirms the long-term viability of the kernels once ensconced in succulent Judean dates, a fruit cultivar lost for centuries. The results make it an excellent candidate for studying the longevity of plant seeds. From those date palm saplings, the researchers have begun to unlock the secrets of the highly sophisticated cultivation practices that produced the dates praised by Herodotus, Galen, and Pliny the Elder.

First, they collected fragments of the seed shells still clinging to the roots of the plants. These were perfect for radiocarbon dating -- which confirmed the seeds date back to between 1,800 and 2,400 years ago. Then, the researchers could conduct genetic analyses of the plants themselves, comparing them to a genetic database of current data palms. This showed exchanges of genetic material from eastern date palms from the Middle East, and western date palms from North Africa.

Indeed, the researchers found that the ancient seeds were up to 30 percent larger than date seeds today, which probably meant the fruit was larger, too.

And, of course, there's the seemingly miraculous germination after so many centuries. As anyone who buys seeds for their garden knows, seeds deteriorate; the longer you have a packet of seeds sitting in storage, the fewer will germinate when you finally plant them. If scientists can discover how the date seeds retained their viability for so long, that could have important implications for agriculture.

Science

How 'MICE' Brings a Muon Collider Closer To Reality (symmetrymagazine.org) 15

"Scientists have announced a breakthrough that could be key to the creation of a powerful new kind of particle collider," reports the Fermilab/SLAC magazine Symmetry.

Long-time Slashdot reader fahrbot-bot shared their report: As reported in the journal Nature, the Muon Ionization Cooling Experiment, or MICE, has for the first time demonstrated the successful taming of a beam of particles called muons through a process called transverse ionization cooling, and the more potential you have to make discoveries as that energy converts into new particles...

Muons — which are heavy relatives of electrons — are interesting to accelerator scientists for a number of reasons. For one, they are more massive than the particles they have traditionally used in colliders. The more massive the particles you collide, the higher the energies you can reach with your collisions, and the more potential you have to make discoveries as that energy converts into new particles... Scientists have thus far stuck to colliding particles such as protons, antiprotons, electrons, positrons and ions. One reason for this is the difficulty of producing a sufficient amount of muons and funneling them into an organized beam for an accelerator to propel and collide...

MICE scientists passed a beam of muons through an absorber, slowing down their momentum perpendicular to the beam direction and focusing them into a tight beam. They then used radio-frequency cavities to speed up the momentum of the beam in the forward direction. They repeated this until they were left with a focused, well-behaved beam of muons traveling the right way.

The scientists undertook the difficult task of measuring each particle one-by-one to evaluate their efforts. They found that they had achieved what they set out to do, bringing scientists a step closer to potentially making a muon collider a reality.

Science

Researchers Develop System That Transforms CO2 Into Concrete (ieee.org) 76

An anonymous reader quotes a report from IEEE Spectrum: A team from the University of California, Los Angeles, has developed a system that transforms "waste CO2" into gray blocks of concrete. In March, the researchers will relocate to the Wyoming Integrated Test Center, part of the Dry Fork power plant near the town of Gillette. During a three-month demonstration, the UCLA team plans to siphon half a ton of CO2 per day from the plant's flue gas and produce 10 tons of concrete daily. Carbon Upcycling UCLA is one of 10 teams competing in the final round of the NRG COSIA Carbon XPrize. The global competition aims to develop breakthrough technologies for converting carbon emissions into valuable products.

The UCLA initiative began about six years ago, as researchers contemplated the chemistry of Hadrian's Wall -- the nearly 1,900-year-old Roman structure in northern England. Masons built the wall by mixing calcium oxide with water, then letting it absorb CO2 from the atmosphere. The resulting reactions produced calcium carbonate, or limestone. But that cementation process can take years or decades to complete, an unimaginably long wait by today's standards. "We wanted to know, 'How do you make these reactions go faster?'" Gaurav Sant, a civil engineering professor who leads the team, recalled. The answer was portlandite, or calcium hydroxide. The compound is combined with aggregates and other ingredients to create the initial building element. That element then goes into a reactor, where it comes in contact with the flue gas coming directly out of a power plant's smokestack. The resulting carbonation reaction forms a solid building component akin to concrete. The UCLA system is unique among green concrete technologies because it doesn't require the expensive step of capturing and purifying CO2 emissions from power plants. Sant said his team's approach is the only one so far that directly uses the flue gas stream. The group has formed a company, CO2Concrete, to commercialize their technology with construction companies and other industrial partners.

Science

Scientists Discover Virus With No Recognizable Genes (sciencemag.org) 104

sciencehabit shares a report from Science Magazine: Viruses are some of the most mysterious organisms on Earth. They're among the world's tiniest lifeforms, and because none can survive and reproduce without a host, some scientists have questioned whether they should even be considered living things. Now, scientists have discovered one that has no recognizable genes, making it among the strangest of all known viruses. But how many viruses do we really know? Another group has just discovered thousands of new viruses hiding out in the tissues of dozens of animals. The finds speak to 'how much we still need to understand' about viruses, says one of the researchers, Jonatas Abrahao, a virologist at the Federal University of Minas Gerais, Belo Horizonte.

Abrahao made his discovery while hunting down giant viruses. These microbes -- some the size of bacteria -- were first discovered in amoebae in 2003. In a local artificial lake, he and his colleagues found not only new giant viruses, but also a virus that -- because of its small size -- was unlike most that infect in amoebae. They named it Yaravirus. (Yara is the "mother of waters" according to Indigenous Tupi-Guarani mythology.) Yaravirus's size wasn't the only thing weird about it. When the team sequenced its genome, none of its genes matched any scientists had come across before, the group reports on the bioRxiv preprint server.

Software

NASA Safety Panel Calls For Reviews After Second Starliner Software Problem (spacenews.com) 83

A second software problem during a CST-100 Starliner test flight is prompting a NASA safety panel to recommend a review of Boeing's software verification processes. Space News reports: That new software problem, not previously discussed by NASA or Boeing, was discussed during a Feb. 6 meeting of NASA's Aerospace Safety Advisory Panel that examined the December uncrewed test flight of Starliner that was cut short by a timer error. That anomaly was discovered during ground testing while the spacecraft was in orbit, panel member Paul Hill said. "While this anomaly was corrected in flight, if it had gone uncorrected, it would have led to erroneous thruster firings and uncontrolled motion during [service module] separation for deorbit, with the potential for a catastrophic spacecraft failure," he said.

The exact cause of the failure remains under investigation by Boeing and NASA, who are also still examining the timer failure previously reported. Those problems, Hill said, suggested broader issues with how Boeing develops and tests the software used by the spacecraft. "The panel has a larger concern with the rigor of Boeing's verification processes," he said. The panel called for reviews of Boeing's flight software integration and testing processes. "Further, with confidence at risk for a spacecraft that is intended to carry humans in space, the panel recommends an even broader Boeing assessment of, and corrective actions in, Boeing's [systems engineering and integration] processes and verification testing." The panel added that all those investigations and reviews be completed as "required input for a formal NASA review to determine flight readiness for either another uncrewed flight test or proceeding directly to a crewed test flight."

Medicine

First Clinical Trial of Gene Editing To Help Target Cancer (arstechnica.com) 23

An anonymous reader quotes a report from Ars Technica: Today, scientists are releasing the results of a clinical trial designed to test the safety of gene editing as a way of fighting cancer. The results are promising, in that a version of the CRISPR gene-editing system that's already a few years out of date appears to be safe when used to direct immune cells to attack cancer. But the cancers that it was meant to treat simply evolved ways of slipping past immune surveillance. For the clinical trial, this gene-editing system has been combined with recently developed immune therapies that target cancer. There is a class of immune T cells that kill cells recognized as foreign, either because they come from a different person (such as after an organ transplant) or because they are infected with a bacteria or virus. These cells can also recognize and attack cancer but often don't, in part because cancer cells are so similar to healthy ones. People have engineered versions of the T cells' recognition system that specifically target cancer cells, and placed these back into patients, helping the immune system attack the cancer, sometimes with spectacular results. As part of the clinical trial, gene editing was used to improve the efficiency of the cancer-targeting T cells. This was done in two different ways.

The first was to target a gene that normally functions to tone down the immune system (called PDCD1). There has been evidence generated in mice that using antibodies that block the protein made from this gene will increase the immune system's attack on cancers. For this work, the researchers targeted the CRISPR system to delete part of the gene itself, inactivating it. This poses a potential risk, as a failure to tone down the immune response can lead to problematic conditions such as autoimmune diseases. The other way gene editing was used was to knock out the T cell's normal system for recognizing foreign cells, called the T cell receptor (TCR). The TCR is composed of two related proteins that form a binary receptor complex. Engineered versions of this protein are the ones used to get cells to recognize and kill cancer. Normally, these engineered versions of the TCR are simply inserted into an immune cell, where both they and the cell's normal TCR genes are also active. The result is four different TCR parts active at the same time, resulting in a variety of hybrid TCRs. At best, these are ineffective and will reduce the total amount of active TCR in a cell. At worst, they'll cause the T cell to attack healthy cells. For the trial, the researchers generated CRISPR constructs that targeted the cell's normal TCR genes. When successfully deleted, this would ensure that the only TCR on the cell's surface would recognize cancer cells.
The researchers ended up working with a total of three patients that had cancers recognized by a known version of the TCR genes.

"While the rates of successful editing were high, the procedure is nowhere near 100 percent effective, and rates of editing varied from nearly half down to 15 percent, depending on the gene," the report says. It adds: "There were no serious adverse affects of the T cell infusions, no sign of a problematic immune response, and the cells persisted in the patients up to nine months after the transfusions, indicating they were tolerated well. [...] The response to the tumor, however, was limited. Two patients appeared to stabilize, while the third showed a response in some tissues but not in others. Ultimately, however, the disease began to progress again, and one of the patients has since died."
Earth

Company To Harvest Green Hydrogen From Underground Oil Fires (sciencemag.org) 107

sciencehabit shares a report from Science Magazine: This month, on the frozen plains of Saskatchewan in Canada, workers began to inject steam and air into the Superb field, a layer of sand 700 meters down that holds 200 million barrels of thick, viscous oil. Their goal was not to pump out the oil, but to set it on fire -- spurring underground chemical reactions that churn out hydrogen gas, along with carbon dioxide (CO2). Eventually, the company conducting the $3 million field test plans to plug its wells with membranes that would allow only the clean-burning hydrogen to reach the surface. The CO2, and all of its power to warm the climate, would remain sequestered deep in the earth. Markets are growing for hydrogen as a fuel for power, heat, and transport, because burning it only releases water. But most hydrogen is made from natural gas, through a process that spews carbon into the air, or by electrolyzing water, which is pricey. Proton Technologies says it can cut costs by relying on oil reservoirs shunned by drillers because they are water-logged or because their oil is too thick.
Businesses

SpaceX Plans a Spinoff, IPO For Starlink Business 28

Thelasko shares a report from Bloomberg: Elon Musk's SpaceX plans to spin out and pursue a public offering of its budding space-internet business Starlink, giving investors a chance to buy into one of the most promising operations within the closely held company. Space Exploration Technologies Corp. has already launched more than 240 satellites to build out Starlink, which will start delivering internet services to customers from space this summer, President Gwynne Shotwell said Thursday at a private investor event hosted by JPMorgan Chase & Co. in Miami. "Right now, we are a private company, but Starlink is the right kind of business that we can go ahead and take public," said Shotwell, SpaceX's chief operating officer. "That particular piece is an element of the business that we are likely to spin out and go public."

Investors have to this point had limited ways to own a piece of SpaceX, which has become one of the most richly valued venture-backed companies in the U.S. by dominating the commercial rocket industry. It flies satellites into orbit for customers including the U.S. military, carries cargo to the International Space Station and aims to start flying NASA astronauts and high-paying tourists soon. But the rocket-launch business remains competitive and tough. Starlink and its ability to provide high-speed internet across the globe has helped private investors in SpaceX justify a roughly $33 billion valuation. Musk has long maintained that the parent is unlikely to go public until it is regularly ferrying people to Mars.

Slashdot Top Deals